Clinical Trials Logo

Filter by:
NCT ID: NCT06340893 Not yet recruiting - Clinical trials for Developmental Language Disorder

Exercise Training in Children With Communication Impairments

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This clinical trial study has two goals. The first goal is to establish fitness levels, participation in physical activities, and fine/gross motor abilities for children with development language disorder (DLD). DLD occurs in 1/13 children and children with DLD often have poorer fine/gross motor skills than those with typical development. The second goal is to determine whether physical exercise helps children with DLD and typical development to learn better and improve fitness and fine/gross motor abilities more than participating in restful play activities. All children (DLD and typically developing) will undergo communication, fine/gross motor and fitness testing. Children will be randomly assigned to participate in an exercise program (n =20) or to a restful play program (n = 20). Both programs will take place 3x/week for 6 weeks and children will only participate in one of the two programs. Children in the exercise program will do activities to train cardiovascular fitness, agility, balance, strength, and endurance while children in the restful play condition will do things like play with legos and color. Researchers will compare changes in learning tasks and fitness levels for children (DLD and typically developing) who participated in the exercise program vs. restful play program.

NCT ID: NCT06340672 Not yet recruiting - Clinical trials for Anterior Cervical Discectomy and Fusion

The Effect of AR in Patient Pre-operative Education

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to analyze the effect of augmented reality (AR) on patient education and overall satisfaction when used during preoperative counseling in adults undergoing spinal surgery. The main aims of this study are: Aim 1: To determine if the use of AR in preoperative consultations is associated with higher levels of patient satisfaction, higher levels of confidence in surgeons, lower levels of preoperative anxiety, and lower patient reported pain scores. Aim 2: To determine if the use of AR in preoperative consultation will enhance patient education and understanding during the surgical consent process and lead to higher patient retention rates and new patient referrals. This study will compare AR enhanced preoperative patient counseling with conventional preoperative counseling practices.

NCT ID: NCT06339463 Not yet recruiting - Anxiety Disorders Clinical Trials

Self-Distancing for Pediatric Anxiety and OCD

Start date: May 2024
Phase: N/A
Study type: Interventional

Self-Distancing is a cognitive technique that involves shifting perspective away from first person to promote an adaptive, self-reflective stance in emotionally charged situations. This trial aims to help learn how self-distancing may increase approach during exposure and thereby improve treatment response. To find out if self-distancing works by helping children approach fear inducing stimuli, the study will look at behaviors related to approach as well as symptom severity, before, after and during treatment. The study hypothesizes that Self-Distancing will produce greater increases in approach behaviors and greater decreases in anxiety severity than in the Classic Exposure.

NCT ID: NCT06339203 Not yet recruiting - Clinical trials for Cesarean Section Complications

Intraoperative Wound Irrigation in Cesarean Section

Start date: June 2024
Phase: N/A
Study type: Interventional

This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.

NCT ID: NCT06339034 Not yet recruiting - Parkinson Disease Clinical Trials

Repurposing Lithium for Parkinson's Disease: a RCT

Start date: June 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.

NCT ID: NCT06338774 Not yet recruiting - Physical Inactivity Clinical Trials

Cognitive Control to Boost Physical Activity Adherence

BOOST
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

This trial is designed to develop and test the efficacy of cognitive training strategies to improve self-regulatory capacities for middle-aged adults to adopt and sustain a physically active lifestyle. The main questions it aims to answer are: - Can cognitive training designed to improve cognitive control improve physical activity adherence? - What are the psychological, physiological, cognitive, and sociodemographic factors that affect the impact of cognitive control on physical activity adherence? Participants will - Complete a 6-week home-based, computerized cognitive training program - Complete a 6-week home-based, aerobic exercise training program with supervision of a health coach and trainer - Complete a 6-week home-based, aerobic exercise training program prescribed by a health coach and trainer - Visit the laboratory before and after cognitive training, and before and after physical training, to complete assessments of cognition and aerobic fitness

NCT ID: NCT06338748 Not yet recruiting - Clinical trials for Continuous Glucose Monitoring

Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery

DexcomG7
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

This is a prospective longitudinal study to study the agreement between a continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the Cardiovascular Intensive Care Unit (CVICU), and by Point of Care (POC) fingerstick glucose using the Accucheck Inform II on the regular floors, and the CGMS reading at the same time will be captured. Subjects will have measurements taken throughout their stay in the CVICU and on the regular floors. Agreement and correlation between systems, as well as errors, will be calculated.

NCT ID: NCT06338384 Not yet recruiting - Clinical trials for Peripheral Neuropathy

Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research

Start date: April 2025
Phase:
Study type: Observational

This trial aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in peripheral neuropathy clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors. Ultimately, this trial endeavors to deepen our understanding of the factors impacting peripheral neuropathy clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.

NCT ID: NCT06338358 Not yet recruiting - Plaque Psoriasis Clinical Trials

Understanding Participation Habits Among Plaque Psoriasis Patients

Start date: April 2025
Phase:
Study type: Observational

The study intends to investigate the personal experiences of plaque psoriasis patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all plaque psoriasis as well as those in under-represented demographic groups.

NCT ID: NCT06338267 Not yet recruiting - Rett Syndrome Clinical Trials

Validation of Innovative Biosensors for Rett Autonomic Symptom Tracking

VIBRANT
Start date: May 2024
Phase:
Study type: Observational

The VIBRANT study aims to validate biosensors to objectively and directly measure symptoms in Rett syndrome and create confidence in the use of these devices in clinical trials. VIBRANT will use several FDA-cleared wearable biosensors and a non-wearable device to collect symptom data from patients with Rett syndrome for up to 9 weeks. Symptoms of interest include heart rate, breathing, sleep, blood oxygen levels, and movement. Participants will use the biosensors intermittently at home, document device use and symptom status, and will come to the clinic for 1 overnight sleep study. A cohort of up to 10 participants receiving an intervention in a separate clinical trial may also enroll and participate on a custom device schedule for up to 1 year. The study will provide information on the feasibility and ease of use for families at home, biosensor data will be compared to data collected at the same time from the overnight sleep study to demonstrate how well they work in individuals with Rett syndrome, and Emerald will be developed to include movement as a measurable symptom.